Additional Paid in Capital in USD of Axcella Health Inc. from Q4 2018 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.
Summary
Axcella Health Inc. quarterly Additional Paid in Capital history and change rate from Q4 2018 to Q2 2023.
  • Axcella Health Inc. Additional Paid in Capital for the quarter ending 30 Jun 2023 was $423M, a 9.46% increase year-over-year.
Additional Paid in Capital, Quarterly (USD)
Additional Paid in Capital, YoY Quarterly Change (%)

Axcella Health Inc. Quarterly Additional Paid in Capital (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2023 $423M +$36.6M +9.46% 30 Jun 2023 10-Q 03 Aug 2023
Q1 2023 $423M +$36.9M +9.55% 31 Mar 2023 10-Q 04 May 2023
Q4 2022 $423M +$63.3M +17.6% 31 Dec 2022 10-Q 03 Aug 2023
Q3 2022 $388M +$32.9M +9.28% 30 Sep 2022 10-Q 01 Nov 2022
Q2 2022 $387M +$35.1M +9.98% 30 Jun 2022 10-Q 12 Aug 2022
Q1 2022 $386M +$36.7M +10.5% 31 Mar 2022 10-Q 05 May 2022
Q4 2021 $359M +$11.3M +3.24% 31 Dec 2021 10-K 30 Mar 2023
Q3 2021 $355M +$8.73M +2.52% 30 Sep 2021 10-Q 10 Nov 2021
Q2 2021 $352M +$13.9M +4.11% 30 Jun 2021 10-Q 29 Jul 2021
Q1 2021 $349M +$71.6M +25.8% 31 Mar 2021 10-Q 06 May 2021
Q4 2020 $348M +$71.7M +26% 31 Dec 2020 10-K 30 Mar 2022
Q3 2020 $346M +$71.5M +26% 30 Sep 2020 10-Q 12 Nov 2020
Q2 2020 $338M +$64.9M +23.8% 30 Jun 2020 10-Q 05 Aug 2020
Q1 2020 $278M +$269M +3211% 31 Mar 2020 10-Q 11 May 2020
Q4 2019 $276M +$269M +3690% 31 Dec 2019 10-K 17 Mar 2021
Q3 2019 $275M 30 Sep 2019 10-Q 12 Nov 2019
Q2 2019 $273M 30 Jun 2019 10-Q 12 Aug 2019
Q1 2019 $8.39M 31 Mar 2019 10-Q 20 Jun 2019
Q4 2018 $7.29M 31 Dec 2018 10-K 23 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.